IDH2 and astrocytoma (excluding glioblastoma): Mutations in the isocitrate dehydrogenase (IDH) genes (IDH1/IDH2) are a critical marker in these tumors, with IDH-mutant astrocytomas generally exhibiting a more favorable prognosis compared to their IDH-wildtype counterparts [21,22,23].